Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |